Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,450 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
Kahaly GJ, Riedl M, König J, Pitz S, Ponto K, Diana T, Kampmann E, Kolbe E, Eckstein A, Moeller LC, Führer D, Salvi M, Curro N, Campi I, Covelli D, Leo M, Marinò M, Menconi F, Marcocci C, Bartalena L, Perros P, Wiersinga WM; European Group on Graves' Orbitopathy (EUGOGO). Kahaly GJ, et al. Among authors: marino m. Lancet Diabetes Endocrinol. 2018 Apr;6(4):287-298. doi: 10.1016/S2213-8587(18)30020-2. Epub 2018 Jan 31. Lancet Diabetes Endocrinol. 2018. PMID: 29396246 Clinical Trial.
Current medical management of Graves ophthalmopathy.
Marcocci C, Bartalena L, Marinò M, Rocchi R, Mazzi B, Menconi F, Morabito E, Pinchera A. Marcocci C, et al. Among authors: marino m. Ophthalmic Plast Reconstr Surg. 2002 Nov;18(6):402-8. doi: 10.1097/00002341-200211000-00003. Ophthalmic Plast Reconstr Surg. 2002. PMID: 12439051 Review. No abstract available.
Long-term safety of orbital radiotherapy for Graves' ophthalmopathy.
Marcocci C, Bartalena L, Rocchi R, Marinò M, Menconi F, Morabito E, Mazzi B, Mazzeo S, Sartini MS, Nardi M, Cartei F, Cionini L, Pinchera A. Marcocci C, et al. Among authors: marino m. J Clin Endocrinol Metab. 2003 Aug;88(8):3561-6. doi: 10.1210/jc.2003-030260. J Clin Endocrinol Metab. 2003. PMID: 12915636
Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: a control mechanism for thyroid hormone release.
Lisi S, Pinchera A, McCluskey RT, Willnow TE, Refetoff S, Marcocci C, Vitti P, Menconi F, Grasso L, Luchetti F, Collins AB, Marino M. Lisi S, et al. Among authors: marino m. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14858-63. doi: 10.1073/pnas.2432267100. Epub 2003 Dec 1. Proc Natl Acad Sci U S A. 2003. PMID: 14657389 Free PMC article.
Thyroid dysfunction in megalin deficient mice.
Lisi S, Segnani C, Mattii L, Botta R, Marcocci C, Dolfi A, McCluskey RT, Pinchera A, Bernardini N, Marinò M. Lisi S, et al. Among authors: marino m. Mol Cell Endocrinol. 2005 May 31;236(1-2):43-7. doi: 10.1016/j.mce.2005.03.009. Mol Cell Endocrinol. 2005. PMID: 15878230
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
McKeag D, Lane C, Lazarus JH, Baldeschi L, Boboridis K, Dickinson AJ, Hullo AI, Kahaly G, Krassas G, Marcocci C, Marinò M, Mourits MP, Nardi M, Neoh C, Orgiazzi J, Perros P, Pinchera A, Pitz S, Prummel MF, Sartini MS, Wiersinga WM; European Group on Graves' Orbitopathy (EUGOGO). McKeag D, et al. Among authors: marino m. Br J Ophthalmol. 2007 Apr;91(4):455-8. doi: 10.1136/bjo.2006.094607. Epub 2006 Oct 11. Br J Ophthalmol. 2007. PMID: 17035276 Free PMC article.
A treatment strategy for Graves' orbitopathy.
Marcocci C, Pinchera A, Marinò M. Marcocci C, et al. Among authors: marino m. Nat Clin Pract Endocrinol Metab. 2007 May;3(5):430-6. doi: 10.1038/ncpendmet0500. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17452970
2,450 results